The Enterprise Value as of September 2024 (TTM) for Theralink Technologies, Inc. (THER) is 19.38M

According to Theralink Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.38M. This represents a change of -27.55% compared to the average of 26.75M of the last 4 quarters.

Theralink Technologies, Inc. (THER) Historical Enterprise Value (quarterly & annually)

How has THER Enterprise Value performed in the past?

The mean historical Enterprise Value of Theralink Technologies, Inc. over the last ten years is 76.49M. The current 19.38M Enterprise Value has changed 2.43% with respect to the historical average. Over the past ten years (40 quarters), THER's Enterprise Value was at its highest in in the February 2015 quarter at 98.19B. The Enterprise Value was at its lowest in in the September 2020 quarter at -1264772.10.

Theralink Technologies, Inc. (THER) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theralink Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theralink Technologies, Inc. (THER) Average Enterprise Value

How has THER Enterprise Value performed in the past?

The current Enterprise Value of Theralink Technologies, Inc. (THER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theralink Technologies, Inc. (THER) Enterprise Value vs. Peers

How is THER’s Enterprise Value compared to its peers?

Theralink Technologies, Inc.’s Enterprise Value is less than Adhera Therapeutics, Inc. (0), greater than GB Sciences, Inc. (10.80M), greater than SciSparc Ltd. (4.56M), greater than Creative Medical Technology Holdings, Inc. (-1381116.00), greater than Regen BioPharma, Inc. (-3309892.00), greater than Enzolytics Inc. (1.26M), less than Sonnet BioTherapeutics Holdings, Inc. (207.05M), greater than Inhibikase Therapeutics, Inc. (2.01M), greater than Sio Gene Therapies Inc. (5.75M), greater than Kaleido Biosciences, Inc. (-15427292.00), greater than Tempest Therapeutics, Inc. (4.26K), less than Lexaria Bioscience Corp. (24.67M), less than Navidea Biopharmaceuticals, Inc. (0), less than ZyVersa Therapeutics, Inc. (41.49M), greater than Biodexa Pharmaceuticals Plc (-2504975.00), greater than Oncorus, Inc. (2.32M), greater than null (-5433123.06), less than null (51.18M),

Build a custom stock screener for Theralink Technologies, Inc. (THER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralink Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theralink Technologies, Inc. (THER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theralink Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.